Ikeda, Japan

Sawada Takeshi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Sawada Takeshi in Pharmaceutical Formulations**

Introduction

Sawada Takeshi, an accomplished inventor based in Ikeda, Japan, has made significant contributions to the pharmaceutical field. With a focus on innovative formulations, he holds one patent that showcases his expertise and commitment to advancing medical science.

Latest Patents

Takeshi's notable patent is titled "Solid Telmisartan Pharmaceutical Formulations." This patent details a pharmaceutical composition that comprises between 3 wt. % to 50 wt. % telmisartan, which is dispersed in a dissolving matrix. This innovative approach enhances the effectiveness of telmisartan, a medication used primarily for managing hypertension and heart failure.

Career Highlights

Sawada Takeshi has established himself at Boehringer Ingelheim International GmbH, a global leader in the pharmaceutical industry. His role at the company demonstrates his alignment with cutting-edge research and development practices, particularly in the realm of pharmaceutical formulations that address critical healthcare needs.

Collaborations

Throughout his career, Takeshi has collaborated with esteemed colleagues, including Manabu Nakatani and Toshimitsu Ohki. These partnerships highlight the importance of teamwork in innovation and the collective effort needed to advance pharmaceutical research and development.

Conclusion

In summary, Sawada Takeshi's contributions, particularly through his patent on solid telmisartan formulations, illustrate the vital role inventors play in the pharmaceutical industry. His affiliations with Boehringer Ingelheim International GmbH and collaborations with other professionals foster an environment ripe for innovation and improvement in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…